Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$951K Buy
7,902
+103
+1% +$11.9K 0.68% 43
2025
Q4
$821K Buy
7,799
+100
+1% +$9.39K 0.62% 49
2025
Q3
$646K Hold
7,699
0.5% 61
2025
Q2
$609K Buy
+7,699
New +$612K 0.51% 61

Other funds holding MRK

Rexford Capital's MRK Position: Q1 2026 in Review

Rexford Capital increased its Merck (MRK) stake by 1.3% in Q1 2026, buying an estimated $11.9K and bringing the position to 7,902 shares worth $951K. The position accounts for 0.68% of the portfolio, ranked #43.

Rexford Capital first reported a position in MRK in Q2 2025 and has held it in 4 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Rexford Capital held 7,902 shares of Merck worth $951K as of Q1 2026.
  • Rexford Capital bought 103 Merck shares in Q1 2026, an estimated $11.9K.
  • Merck made up 0.68% of Rexford Capital's portfolio in Q1 2026, its #43 holding.
  • Rexford Capital first reported a position in Merck in Q2 2025 and has held it in 4 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Rexford Capital's 13F filing for Q1 2026, filed 24 Apr 2026.